Neurocrine Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Neurocrine Biosciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 27% to $1,887,100,000. The net income raised on $249,700,000 and profit margin reached 13%. Total operating expenses were $1,596,500,000.
Profit Margin
| 2014 | 0 | -60.54M | |
|---|---|---|---|
| 2015 | 19.76M | -88.92M | -449.84% |
| 2016 | 15M | -141.09M | -940.6% |
| 2017 | 161.62M | -142.54M | -88.19% |
| 2018 | 451.24M | 21.11M | 4.68% |
| 2019 | 788.1M | 37M | 4.69% |
| 2020 | 1.04B | 407.3M | 38.94% |
| 2021 | 1.13B | 89.6M | 7.9% |
| 2022 | 1.48B | 154.5M | 10.38% |
| 2023 | 1.88B | 249.7M | 13.23% |
0K6R.L Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 1.88B | 1.48B | 1.13B | 1.04B | 788.1M | 451.24M | 161.62M | 15M | 19.76M | 0 |
Cost of revenue | 39.7M | 23.2M | 14.3M | 10.1M | 7.4M | 4.88M | 1.25M | 0 | 33.8M | 14.4M |
Gross profit | 1.84B | 1.46B | 1.11B | 1.03B | 780.7M | 446.35M | 160.37M | 15M | -14.03M | -14.4M |
Operating exp. | ||||||||||
Research and development | 565M | 463.8M | 328.1M | 275M | 200M | 160.52M | 121.82M | 94.29M | 81.49M | 46.42M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 1.59B | 1.21B | 911.4M | 708.3M | 554.1M | 409.45M | 291.73M | 162.37M | 113.97M | 64.41M |
Operating income | 250.9M | 249M | 196.9M | 318.9M | 219.14M | 36.89M | -131.36M | -147.37M | -94.20M | -64.41M |
Other income (expenses), net | 81.2M | -35.1M | -95.5M | -56.3M | -172.64M | 15.47M | -11.18M | 6.28M | 5.27M | 3.86M |
Income before tax | 332.1M | 213.9M | 101.4M | 106.7M | 46.5M | 21.84M | -142.54M | -141.09M | -88.92M | -60.54M |
Income tax expense | 82.4M | 59.4M | 11.8M | -300.6M | 9.5M | 730K | 17.10M | -7.72M | -6.27M | -4.67M |
Net income | 249.7M | 154.5M | 89.6M | 407.3M | 37M | 21.11M | -142.54M | -141.09M | -88.92M | -60.54M |
Earnings per share | ||||||||||
Basic EPS | 2.56 | 1.61 | 0.95 | 4.37 | 0.4 | 0.22 | -1.62 | -1.63 | -1.05 | -0.81 |
Diluted EPS | 2.47 | 1.56 | 0.92 | 4.16 | 0.39 | 0.22 | -1.62 | -1.63 | -1.05 | -0.81 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |